Mathematical modeling and computer simulation of erythrocytapheresis for SCD

Area of Science:

• Hematology
• Medical Informatics
• Computational Biology

Background:

• Erythrocytapheresis is crucial for preventing complications like stroke in sickle cell disease (SCD).
• Current regimens carry risks including iron overload and transfusion-transmitted infections.
• Computer modeling offers a potential solution to optimize these treatments and mitigate risks.

Purpose of the Study:

• To develop and validate a computer model for simulating erythrocytapheresis in SCD patients.
• To assess the model's accuracy in predicting hemoglobin S (HbS) levels post-treatment and pre-treatment.

Main Methods:

• Mathematical models based on material balance and patient-specific statistics were created.
• These models estimated HbS levels immediately after and before subsequent erythrocytapheresis treatments.
• A software application simulated various treatment parameters across 90 procedures for four patients.

Main Results:

• The model accurately predicted immediate postprocedure HbS levels (R² = 0.83–0.96).
• Pre-treatment HbS level predictions showed good correlation in most patients (R² = 0.71–0.83), but were less accurate in one (R² = 0.28–0.46).
• Simulations demonstrated significant variability in red blood cell (RBC) units and net volume transfused based on treatment adjustments.

Conclusions:

• Computer modeling effectively simulates erythrocytapheresis for sickle cell disease (SCD) management.
• This technology can optimize chronic treatment regimens.
• Modeling holds potential for minimizing risks associated with overtransfusion in SCD patients.